These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 23575708

  • 21. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 22. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP.
    Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488
    [Abstract] [Full Text] [Related]

  • 23. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.
    Hypertension; 2014 Sep 01; 64(3):565-72. PubMed ID: 24935940
    [Abstract] [Full Text] [Related]

  • 24. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD.
    Int J Cardiol; 2013 Oct 03; 168(3):2214-20. PubMed ID: 23453868
    [Abstract] [Full Text] [Related]

  • 25. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.
    EuroIntervention; 2015 Feb 03; 10(10):1213-20. PubMed ID: 25452197
    [Abstract] [Full Text] [Related]

  • 26. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM, Eeftinck Schattenkerk DW, Dobrowolski LC, de Winter RJ, Reekers JA, Verberne HJ, Vogt L, van den Born BJ.
    Int J Cardiol; 2016 Jan 01; 202():609-14. PubMed ID: 26447672
    [Abstract] [Full Text] [Related]

  • 27. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 01; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]

  • 28. The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients.
    Vink EE, Verloop WL, Siddiqi L, van Schelven LJ, Liam Oey P, Blankestijn PJ.
    Int J Cardiol; 2014 Sep 01; 176(1):8-12. PubMed ID: 25027168
    [Abstract] [Full Text] [Related]

  • 29. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation.
    Chen W, Ling Z, Du H, Song W, Xu Y, Liu Z, Su L, Xiao P, Yuan Y, Lu J, Zhang J, Li Z, Shao J, Zhong B, Zhou B, Woo K, Yin Y.
    Catheter Cardiovasc Interv; 2016 Nov 01; 88(5):786-795. PubMed ID: 27219520
    [Abstract] [Full Text] [Related]

  • 30. Mid-Term Vascular Safety of Renal Denervation Assessed by Follow-up MR Imaging.
    Schmid A, Schmieder R, Lell M, Janka R, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2016 Mar 01; 39(3):426-32. PubMed ID: 26253780
    [Abstract] [Full Text] [Related]

  • 31. Renal sympathetic denervation using an externally irrigated radiofrequency ablation catheter for treatment of resistant hypertension - Acute safety and short term efficacy.
    Yalagudri S, Raju N, Das B, Daware A, Maiya S, Jothiraj K, Ravikishore AG.
    Indian Heart J; 2015 Mar 01; 67(3):207-13. PubMed ID: 26138176
    [Abstract] [Full Text] [Related]

  • 32. Percutaneous renal sympathetic denervation: 2013 and beyond.
    Froeschl M, Hadziomerovic A, Ruzicka M.
    Can J Cardiol; 2014 Jan 01; 30(1):64-74. PubMed ID: 24365191
    [Abstract] [Full Text] [Related]

  • 33. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
    Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2015 Apr 07; 65(13):1314-1321. PubMed ID: 25835443
    [Abstract] [Full Text] [Related]

  • 34. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.
    Witkowski A, Prejbisz A, Florczak E, Kądziela J, Śliwiński P, Bieleń P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A.
    Hypertension; 2011 Oct 07; 58(4):559-65. PubMed ID: 21844482
    [Abstract] [Full Text] [Related]

  • 35. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr 07; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 36. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R.
    J Invasive Cardiol; 2014 Jul 07; 26(7):322-7. PubMed ID: 24993989
    [Abstract] [Full Text] [Related]

  • 37. [Renal denervation by trans-radial access for resistant hypertension].
    Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, Benamer H, Groupe ICV-GVM la Roseraie, Aubervilliers, ICPS Massy, Quincy.
    Ann Cardiol Angeiol (Paris); 2014 Dec 07; 63(6):460-4. PubMed ID: 25450996
    [Abstract] [Full Text] [Related]

  • 38. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May 07; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

  • 39. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
    Fischell TA, Ebner A, Gallo S, Ikeno F, Minarsch L, Vega F, Haratani N, Ghazarossian VE.
    JACC Cardiovasc Interv; 2016 Mar 28; 9(6):589-98. PubMed ID: 27013159
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Aug 28; 86(2):299-303. PubMed ID: 23983010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.